Key result
Patients with diabetes exhibited 18-82% higher platelet ATP and ADP levels, thiobarbituric acid-reactive species synthesis, and platelet aggregation compared to healthy participants.
Why the study?
Does chronic hyperglycemia in diabetic patients increase platelet ATP/ADP levels and hyperactivity compared to healthy participants?
Observational
Does chronic hyperglycemia in diabetic patients increase platelet ATP/ADP levels and hyperactivity compared to healthy participants?
Effect estimate: 18-82% higher
Chronic hyperglycemia in diabetes is associated with elevated platelet ATP/ADP levels and increased release, which may underlie platelet hyperactivity and subsequent vascular complications.
May underlie vascular complications in diabetes; hypothesis-generating, requires prospective confirmation.
Increased activity of blood platelets contributes to vascular complications in patients with diabetes. The aim of this work was to investigate whether persisting hyperglycemia in diabetic patients generates excessive accumulation of ATP/ADP, which may underlie platelet hyperactivity. Platelet ATP and ADP levels, thiobarbituric acid-reactive species synthesis, and aggregation of platelets from patients with diabetes were 18-82% higher than in platelets from healthy participants. In patients with diabetes, platelet stimulation with thrombin caused about two times greater release of ATP and ADP than in the healthy group while decreasing intraplatelet nucleotide content to similar levels in both groups. This indicates that the increased content of adenylate nucleotides in the releasable pool in the platelets of diabetic patients does not affect their level in metabolic cytoplasmic/mitochondrial compartments. Significant correlations between platelet ATP levels and plasma fructosamine, as well as between platelet ATP/ADP and platelet activities, have been found in diabetic patients. In conclusion, chronic hyperglycemia-evoked elevations of ATP/ADP levels and release from blood platelets of patients with diabetes may be important factors underlying platelet hyperactivity in the course of the disease.
No takes yet. Share an insight, caveat, or question.
Michno et al. (2007) conducted an observational in Diabetes. Diabetes vs. Healthy participants was evaluated on Platelet ATP and ADP levels, thiobarbituric acid-reactive species synthesis, and aggregation (18-82% higher). Patients with diabetes exhibited 18-82% higher platelet ATP and ADP levels, thiobarbituric acid-reactive species synthesis, and platelet aggregation compared to healthy participants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: